Back to SYRE
Candriam S.C.A. SYRE Position History
Spyre Therapeutics, Inc. • Healthcare
Quarters held
6
Latest value
$40.1M
Q3 2026
Peak value
$48.5M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $6.8M |
| Q4 2025 | $13.9M |
| Q4 2025 | $13.9M |
| Q1 2026 | $30.8M |
| Q2 2026 | $48.5M |
| Q3 2026 | $40.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $40.1M | 448.6K | — | — |
| Q2 2026 | $48.5M | 546.3K | — | — |
| Q1 2026 | $30.8M | 610.3K | — | — |
| Q4 2025 | $13.9M | 425.5K | — | — |
| Q4 2025 | $13.9M | 425.5K | — | — |
| Q3 2025 | $6.8M | 404.4K | — | — |
Other funds holding SYRE
$809.9M
$795.4M
$430.1M
$348.1M
$336.7M
$318.8M